1. Summary
Schizophrenia is a psychiatric disorder that likely arises from a complex series of interactions between genetic and environmental factors, resulting in altered neural connectivity. Consistent with this position, an extensive body of research has demonstrated that the molecular machinery that regulates synaptic activity is altered in post mortem brain tissue in schizophrenia. In particular, the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) protein synaptosomal-associated protein-25 (SNAP-25) and the SNARE-interacting proteins complexin I and II are implicated in the pathophysiology of this disorder. These proteins regulate synaptic neurotransmission and are important for plasticity-associated changes in the brain. Recent evidence from our laboratory has demonstrated that levels of these proteins are decreased in the hippocampus in schizophrenia, and importantly, these decreases are significantly associated with cognitive impairment. These findings represent the first description significantly linking synaptic proteins to cognitive function in schizophrenia. Preclinical studies provide evidence that SNAP-25 and complexins may be implicated in the pathophysiology of additional psychiatric and neurological disorders, as well as in the therapeutic efficacy of drugs used in the treatment of these disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
8. References
Thaker, G.K., and Carpenter, W.T., Jr. (2001) Nat Med 7, 667–671.
Weickert, T.W., Goldberg, T.E., Gold, J.M., Bigelow, L.B., Egan, M.F., and Weinberger, D.R. (2000) Arch Gen Psychiatry 57, 907–913.
Lahti, A.C., Holcomb, H.H., Medoff, D.R., Weiler, M.A., Tamminga, C.A., and Carpenter, W.T., Jr. (2001) Am J Psychiatry 158, 1797–1808.
Andreasen, N.C., O’Leary, D.S., Cizadlo, T., Arndt, S., Rezai, K., Ponto, L.L., Watkins, G.L., and Hichwa, R.D. (1996) Proc Natl Acad Sci U S A 93, 9985–9990.
Honer, W.G., and Young, C.E. (2004) Int Rev Neurobiol 59, 175–199.
Mirnics, K., Middleton, F.A., Marquez, A., Lewis, D.A., and Levitt, P. (2000) Neuron 28, 53–67.
Powchik, P., Davidson, M., Haroutunian, V., Gabriel, S.M., Purohit, D.P., Perl, D.P., Harvey, P.D., and Davis, K.L. (1998) Schizophr Bull 24, 325–341.
Wakabayashi, K., Honer, W.G., and Masliah, E. (1994) Brain Res 667, 24–32.
Marder, S.R., Fenton, W., and Youens, K. (2004) Am J Psychiatry 161, 25.
Fray, P.J., and Robbins, T.W. (1996) Neurotoxicol Teratol 18, 499–504.
Aleman, A., Hijman, R., de Haan, E.H., and Kahn, R.S. (1999) Am J Psychiatry 156, 1358–1366.
Braff, D.L., Geyer, M.A., and Swerdlow, N.R. (2001) Psychopharmacology (Berl) 156, 234–258.
Braff, D.L., and Light, G.A. (2004) Psychopharmacology (Berl) 174, 75–85.
Pantelis, C., Barnes, T.R., Nelson, H.E., Tanner, S., Weatherley, L., Owen, A.M., and Robbins, T.W. (1997) Brain 120, 1823–1843.
Stefani, M.R., Groth, K., and Moghaddam, B. (2003) Behav Neurosci 117, 728–737.
Tunbridge, E.M., Bannerman, D.M., Sharp, T., and Harrison, P.J. (2004) J Neurosci 24, 5331–5335.
McMahon, H.T., Missler, M., Li, C., and Sudhof, T.C. (1995) Cell 83, 111–119.
Pabst, S., Margittai, M., Vainius, D., Langen, R., Jahn, R., and Fasshauer, D. (2002) J Biol Chem 277, 7838–7848.
Eastwood, S.L., Cotter, D., and Harrison, P.J. (2001) Neuroscience 105, 219–229.
Freeman, W., and Morton, A.J. (2004) Brain Res Bull 63, 33–44.
Yamada, M., Saisu, H., Ishizuka, T., Takahashi, H., and Abe, T. (1999) Neuroscience 93, 7–18.
Sawada, K., Barr, A.M., Nakamura, M., Arima, K., Young, C.E., Dwork, A.J., Falkai, P., Phillips, A.G., and Honer, W.G. (2005) Arch Gen Psychiatry 62, 263–272.
Tokumaru, H., Umayahara, K., Pellegrini, L.L., Ishizuka, T., Saisu, H., Betz, H., Augustine, G.J., and Abe, T. (2001) Cell 104, 421–432.
Ono, S., Baux, G., Sekiguchi, M., Fossier, P., Morel, N.F., Nihonmatsu, I., Hirata, K., Awaji, T., Takahashi, S., and Takahashi, M. (1998) Eur J Neurosci 10, 2143–2152.
Reim, K., Mansour, M., Varoqueaux, F., McMahon, H.T., Sudhof, T.C., Brose, N., and Rosenmund, C. (2001) Cell 104, 71–81.
Edwardson, J.M., Wang, C.T., Gong, B., Wyttenbach, A., Bai, J., Jackson, M.B., Chapman, E.R., and Morton, A.J. (2003) J Biol Chem 278, 30849–30853.
Glynn, D., Drew, C.J., Reim, K., Brose, N., and Morton, A.J. (2005) Hum Mol Genet 14, 2369–2385.
Takahashi, S., Ujihara, H., Huang, G.Z., Yagyu, K.I., Sanbo, M., Kaba, H., and Yagi, T. (1999) Eur J Neurosci 11, 2359–2366.
Glynn, D., Bortnick, R.A., and Morton, A.J. (2003) Hum Mol Genet 12, 2431–2448.
Barr, A.M., Young, C.E., Sawada, K., Trimble, W.S., Phillips, A.G., and Honer, W.G. (2004) Eur J Neurosci 20, 303–307.
Kinnunen, A.K., Koenig, J.I., and Bilbe, G. (2003) J Neurochem 86, 736–748.
Barr, A.M., Hofmann, C.E., Phillips, A.G., Weinberg, J., and Honer, W.G. (2005) Alc Clin Exp Res 29, 1915–1920.
Freeman, W., and Morton, A.J. (2004) Brain Res Bull 63, 45–55.
Morton, A.J., Faull, R.L., and Edwardson, J.M. (2001) Brain Res Bull 56, 111–117.
Diprospero, N.A., Chen, E.Y., Charles, V., Plomann, M., Kordower, J.H., and Tagle, D.A. (2004) J Neurocytol 33, 517–533.
Basso, M., Giraudo, S., Corpillo, D., Bergamasco, B., Lopiano, L., and Fasano, M. (2004) Proteomics 4, 3943–3952.
Sawada, K., Young, C.E., Barr, A.M., Longworth, K., Takahashi, S., Arango, V., Mann, J.J., Dwork, A.J., Falkai, P., Phillips, A.G., and Honer, W.G. (2002) Mol Psychiatry 7, 484–492.
Nakahara, T., Motomura, K., Hashimoto, K., Ueki, H., Gotoh, L., Hondo, H., Tsutsumi, T., Kuroki, T., Hirano, M., and Uchimura, H. (2000) Neurosci Lett 290, 29–32.
Zink, M., Rapp, S., Gebicke-Haerter, P.J., Henn, F.A., and Thome, J. (2005) Psychopharmacology (Berl), 1–6.
Harrison, P.J., and Eastwood, S.L. (1998) Lancet 352, 1669–1673.
Harrison, P.J., Law, A.J., and Eastwood, S.L. (2003) Ann N Y Acad Sci 1003, 94–101.
Talbot, K., Eidem, W.L., Tinsley, C.L., Benson, M.A., Thompson, E.W., Smith, R.J., Hahn, C.G., Siegel, S.J., Trojanowski, J.Q., Gur, R.E., Blake, D.J., and Arnold, S.E. (2004) J Clin Invest 113, 1353–1363.
Lee, H.J., Song, J.Y., Kim, J.W., Jin, S.Y., Hong, M.S., Park, J.K., Chung, J.H., Shibata, H., and Fukumaki, Y. (2005) Behav Brain Funct 1, 15.
Bark, I.C., and Wilson, M.C. (1994) Gene 139, 291–292.
Ravichandran, V., Chawla, A., and Roche, P.A. (1996) J Biol Chem 271, 13300–13303.
Chen, D., Minger, S.L., Honer, W.G., and Whiteheart, S.W. (1999) Brain Res 831, 11–24.
Pan, P.Y., Cai, Q., Lin, L., Lu, P.H., Duan, S., and Sheng, Z.H. (2005) J Biol Chem 280, 25769–25779.
Jahn, R., and Sudhof, T.C. (1999) Annu Rev Biochem 68, 863–911.
Oyler, G.A., Polli, J.W., Higgins, G.A., Wilson, M.C., and Billingsley, M.L. (1992) Brain Res Dev Brain Res 65, 133–146.
Oyler, G.A., Higgins, G.A., Hart, R.A., Battenberg, E., Billingsley, M., Bloom, F.E., and Wilson, M.C. (1989) J Cell Biol 109, 3039–3052.
Gonelle-Gispert, C., Halban, P.A., Niemann, H., Palmer, M., Catsicas, S., and Sadoul, K. (1999) Biochem J 339, 159–165.
Hohne-Zell, B., Galler, A., Schepp, W., Gratzl, M., and Prinz, C. (1997) Endocrinology 138, 5518–5526.
Nagy, G., Reim, K., Matti, U., Brose, N., Binz, T., Rettig, J., Neher, E., and Sorensen, J.B. (2004) Neuron 41, 417–429.
Michaelevski, I., Chikvashvili, D., Tsuk, S., Singer-Lahat, D., Kang, Y., Linial, M., Gaisano, H.Y., Fili, O., and Lotan, I. (2003) J Biol Chem 278, 34320–34330.
Rettig, J., Sheng, Z.H., Kim, D.K., Hodson, C.D., Snutch, T.P., and Catterall, W.A. (1996) Proc Natl Acad Sci U S A 93, 7363–7368.
Sakaba, T., Stein, A., Jahn, R., and Neher, E. (2005) Science 309, 491–494.
Washbourne, P., Thompson, P.M., Carta, M., Costa, E.T., Mathews, J.R., Lopez-Bendito, G., Molnar, Z., Becher, M.W., Valenzuela, C.F., Partridge, L.D., and Wilson, M.C. (2002) Nat Neurosci 5, 19–26.
Wilson, M.C. (2000) Neurosci Biobehav Rev 24, 51–57.
Raber, J., Mehta, P.P., Kreifeldt, M., Parsons, L.H., Weiss, F., Bloom, F.E., and Wilson, M.C. (1997) J Neurochem 68, 176–186.
Roberts, L.A., Morris, B.J., and O’Shaughnessy, C.T. (1998) Neuroreport 9, 33–36.
Genoud, S., Pralong, W., Riederer, B.M., Eder, L., Catsicas, S., and Muller, D. (1999) J Neurochem 72, 1699–1706.
Hou, Q., Gao, X., Zhang, X., Kong, L., Wang, X., Bian, W., Tu, Y., Jin, M., Zhao, G., Li, B., Jing, N., and Yu, L. (2004) Eur J Neurosci 20, 1593–1603.
Barr, A.M., Conti, B., Wirz, S., Walker, J., Hayakawa, M., Sanna, P., Pemberton, J., Leonhard, S., Behrens, M., Fehlmann, D., Maier, R., Bilbe, G., Hoyer, D., and Bartfai, T. (2003) Society for Neuroscience Abstracts 28, 957–957.
Nakahara, T., Nakamura, K., Tsutsumi, T., Hashimoto, K., Hondo, H., Hisatomi, S., Motomura, K., and Uchimura, H. (1998) Brain Res Mol Brain Res 61, 238–242.
Barr, A.M., Young, C.E., Phillips, A.G., and Honer, W.G. Int J Neuropsychopharmacol (In press).
Barr, A.M., Young, C.E., Honer, W.G., and Phillips, A.G. (2000) J Psychopharmacol 14Suppl, A64.
Lapiz, M.D., Fulford, A., Muchimapura, S., Mason, R., Parker, T., and Marsden, C.A. (2003) Neurosci Behav Physiol 33, 13–29.
Hess, E.J., Collins, K.A., and Wilson, M.C. (1996) J Neurosci 16, 3104–3111.
Bond, W.S. (1987) Clin Pharm 6, 617–624.
Barr, C.L., Feng, Y., Wigg, K., Bloom, S., Roberts, W., Malone, M., Schachar, R., Tannock, R., and Kennedy, J.L. (2000) Mol Psychiatry 5, 405–409.
Muller, D.J., Klempan, T.A., De Luca, V., Sicard, T., Volavka, J., Czobor, P., Sheitman, B.B., Lindenmayer, J.P., Citrome, L., McEvoy, J.P., Lieberman, J.A., Honer, W.G., and Kennedy, J.L. (2005) Neurosci Lett 379, 81–89.
Thompson, P.M., Sower, A.C., and Perrone-Bizzozero, N.I. (1998) Biol Psychiatry 43, 239–243.
Mukaetova-Ladinska, E.B., Hurt, J., Honer, W.G., Harrington, C.R., and Wischik, C.M. (2002) Neurosci Lett 317, 161–165.
Honer, W.G., Falkai, P., Bayer, T.A., Xie, J., Hu, L., Li, H.Y., Arango, V., Mann, J.J., Dwork, A.J., and Trimble, W.S. (2002) Cereb Cortex 12, 349–356.
Thompson, P.M., Kelley, M., Yao, J., Tsai, G., and van Kammen, D.P. (2003) Biol Psychiatry 53, 1132–1137.
Young, C.E., Arima, K., Xie, J., Hu, L., Beach, T.G., Falkai, P., and Honer, W.G. (1998) Cereb Cortex 8, 261–268.
Fatemi, S.H., Earle, J.A., Stary, J.M., Lee, S., and Sedgewick, J. (2001) Neuroreport 12, 3257–3262.
Thompson, P.M., Egbufoama, S., and Vawter, M.P. (2003) Prog Neuropsychopharmacol Biol Psychiatry 27, 411–417.
Lewis, D.A., Hashimoto, T., and Volk, D.W. (2005) Nat Rev Neurosci 6, 312–324.
Benes, F.M. (1999) Biol Psychiatry 46, 589–599.
Torrey, E.F., Barci, B.M., Webster, M.J., Bartko, J.J., Meador-Woodruff, J.H., and Knable, M.B. (2005) Biol Psychiatry 57, 252–260.
Barr, A.M., Fish, K., Morgan, S., and Markou, A. (2004) Int J Neuropsychopharmacol 7, S436.
Costa, E., Davis, J., Pesold, C., Tueting, P., and Guidotti, A. (2002) Curr Opin Pharmacol 2, 56–62.
Veldic, M., Guidotti, A., Maloku, E., Davis, J.M., and Costa, E. (2005) Proc Natl Acad Sci U S A 102, 2152–2157.
Stefansson, H., Steinthorsdottir, V., Thorgeirsson, T.E., Gulcher, J.R., and Stefansson, K. (2004) Ann Med 36, 62–71.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Barr, A.M., Young, C.E., Sawada, K., Honer, W.G. (2006). Relevance of Presynaptic Proteins to Neuropsychiatric Disorders. In: Dityatev, A., El-Husseini, A. (eds) Molecular Mechanisms of Synaptogenesis. Springer, Boston, MA . https://doi.org/10.1007/978-0-387-32562-0_27
Download citation
DOI: https://doi.org/10.1007/978-0-387-32562-0_27
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-32560-6
Online ISBN: 978-0-387-32562-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)